Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S E Austin

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
MCN. the American Journal of Maternal Child Nursing|March 1, 1980
Family-centered discharge planning classesS E Austin
MCN. the American Journal of Maternal Child Nursing|July 1, 1986
Childbirth classes for couples desiring VBAC (vaginal birth after cesarean)S E Austin
Drug Design and Discovery|August 31, 1999
Rational drug design using trypanothione reductase as a target for anti-trypanosomal and anti-leishmanial drug leadsS E Austin, M O Khan, K T Douglas
Genome Biology|December 6, 2000
An overview of the structures of protein-DNA complexesN M Luscombe, S E Austin, H M Berman, et al.
Journal of Medicinal Chemistry|August 24, 2000
Use of an additional hydrophobic binding site, the Z site, in the rational drug design of a new class of stronger trypanothione reductase inhibitor, quaternary alkylammonium phenothiazinesM O Khan, S E Austin, C Chan, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
MCN. the American Journal of Maternal Child Nursing|March 1, 1980
Family-centered discharge planning classesS E Austin
MCN. the American Journal of Maternal Child Nursing|July 1, 1986
Childbirth classes for couples desiring VBAC (vaginal birth after cesarean)S E Austin
Drug Design and Discovery|August 31, 1999
Rational drug design using trypanothione reductase as a target for anti-trypanosomal and anti-leishmanial drug leadsS E Austin, M O Khan, K T Douglas
Genome Biology|December 6, 2000
An overview of the structures of protein-DNA complexesN M Luscombe, S E Austin, H M Berman, et al.
Journal of Medicinal Chemistry|August 24, 2000
Use of an additional hydrophobic binding site, the Z site, in the rational drug design of a new class of stronger trypanothione reductase inhibitor, quaternary alkylammonium phenothiazinesM O Khan, S E Austin, C Chan, et al.
Pageof 1